Physician profile
Jacob Pennington
NPI 1174915235
$6,259.45
in general payments reported to CMS, 2019-2025
15 companies · $1,004 in 2025
The $1,004 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $464 · 2021: $1,513 · 2022: $781 · 2023: $726 · 2024: $949 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,317 · Travel and Lodging: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,317.15 |
| Travel and Lodging | $362.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,466.98 | 2020-2025 | Rosa, Mymobility Platform, Gel-One Cross-Linked Hyaluronate |
| Stryker Corporation | $1,222.07 | 2020-2024 | Mako, Accolade |
| Depuy Synthes Sales INC. | $908.10 | 2021-2025 | Attune |
| Smith+Nephew, INC. | $891.82 | 2023-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Spatial Frame |
| Medwest Associates | $708.00 | 2019 | |
| Ethicon US, LLC | $294.59 | 2022-2023 | Dermabond Prineo, Vistaseal, Ethicon |
| Linkbio Corp | $271.38 | 2024 | |
| Medical Device Business Services, INC. | $261.00 | 2020 | |
| Medtronic USA, INC. | $77.08 | 2019 | |
| Heraeus Medical, LLC. | $37.90 | 2022 | |
| Boston Scientific Corporation | $37.41 | 2019 | |
| Heron Therapeutics, INC. | $26.09 | 2024 | Zynrelef |
| Solventum Corporation | $21.58 | 2024 | Prevena |
| Pacira Pharmaceuticals Incorporated | $18.08 | 2024 | Iovera, Exparel |
| Avanos Medical | $17.37 | 2023 | Trivisc Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Pennington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.